Articles from Clinisys

Clinisys, a global provider of laboratory informatics solutions, today announced a strategic partnership with Decisions, an enterprise low-code and no-code (LCNC) orchestration and automation platform. Together, the companies will deliver a new approach to laboratory information management system (LIMS) configuration — empowering laboratories to adapt systems more efficiently without compromising control or regulatory requirements.

Clinisys, a global leader in laboratory informatics, today announced the general availability of Clinisys™ Laboratory Solution (CLS) v2025.3, continuing the evolution of its unified platform for scientific and healthcare laboratories.

Clinisys is now enhancing its August 2025 release of Clinisys™ Laboratory Solution (CLS) v2025.1—which delivered significant advancements such as advanced food safety testing, expanded global usability, enhanced quality control, and improved integration capabilities—with its game-changing new healthcare capabilities in CLS v2025.2. These latest innovations, including tailored solutions for Clinical Pathology and Genomics laboratories in North America, empower organizations to accelerate implementation, expand their testing menus, and drive operational excellence. Also included is CLS CARE, an embedded AI-powered chat agent that provides instant, multilingual guidance on functionality, configuration, and usage.

Clinisys today announces the acquisition of Orchard Software from Francisco Partners, a leading global investment firm that specializes in partnering with technology businesses. The acquisition brings together two leaders in the LIS market and reaffirms Clinisys’s continued commitment to provide the laboratory informatics marketplace with cutting edge software advancements. The combined capabilities provide for comprehensive, flexible, and scalable informatics offerings that can better serve customers across the global diagnostics market.